Adragos Pharma is a globally operating Contract Development and Manufacturing Organisation.
Adragos Pharma was founded in 2020 by Andreas Raabe.
1282 health care and life sciences companies are in the directory, 93 of them in the same 251-500 employee range and 184 based in European Union (EU).
Adragos Pharma may be growing as it has been involved in the acquisition of a manufacturing site, which indicates an expansion of its production capabilities. The company, in partnership with Prange Group, has acquired Fresenius Kabi's Norwegian manufacturing site, a move that typically suggests an increase in operational capacity and potential revenue streams. This acquisition is reported in two separate articles, reinforcing the significance of this expansion. Furthermore, the acquisition of a production site is a substantial investment, which is a strong indicator of growth for a Contract Development and Manufacturing Organisation in the pharmaceutical industry.
“Adragos Pharma is your global CDMO for pharma and biotech, streamlining pharmaceutical development and manufacturing for drug products worldwide.” adragos-pharma.com
Adragos Pharma has a 251-500 person team and operates in health care, listed under European Union (EU), and has been around since 2020. Its founder is Andreas Raabe and its website drew about 1,923 visits in the latest month measured.
251-500 employees · abx.de
251-500 employees · ajapharma.com
251-500 employees · acmegrp.in
51-100 employees · acofarma.com
51-100 employees · advacarepharma.com
51-100 employees · arxpharma.com
251-500 employees · ab7group.com
251-500 employees · acandis.com
251-500 employees · 4gclinical.com
251-500 employees · adhesivesresearch.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.